Startups channel feed

Os­car is wind­ing down its small em­ploy­er health plans with Cigna

Last year
Health Tech

Ex­clu­sive: En­gi­neered B cell ther­a­py start­up Walk­ing Fish shuts down

Last year
People

Lab­Cen­tral helped cre­ate 6,300 jobs and 19 IPOs. Amid a slump, de­mand for lab space has slowed

Last year

As dig­i­tal health uni­corns are pres­sured to do more with less, Tran­scar­ent gets a fresh $126M

Last year
Health Tech

Flag­ship com­mits $50M to new start­up that scours vi­ral pro­teins for new drugs

Last year
Financing

As­traZeneca-al­lied Ec­co­gene tar­gets ear­ly 2025 Nas­daq IPO with mul­ti­ple NASH can­di­dates

Last year
Financing

Ex­clu­sive: New York biotech de­buts with $16M to find new ways to make sol­id can­cer cell ther­a­pies

Last year
Financing
Cell/Gene Tx

No­var­tis makes a $1B ra­dio­phar­ma deal, buy­ing Mar­i­ana On­col­o­gy

Last year
Deals
Pharma

Bridge­Bio spins out on­col­o­gy unit with $200M in back­ing for RAS as­sets

Last year
Financing
Deals

A once-pub­lic psy­che­del­ic biotech reemerges with $103M from MPM and No­vo Hold­ings

Last year
Financing

Ex­clu­sive: Spark co-founder launch­es new CNS gene ther­a­py biotech with $54M

Last year
Financing
Cell/Gene Tx

Bris­tol My­ers buys in­to Reper­toire's au­toim­mune vac­cines, giv­ing new life to Flag­ship start­up

Last year
Deals
Pharma

En­deav­or Bio­Med­i­cines snags $132M for Phase 2 fi­bro­sis drug, ADC can­di­date

Last year
Financing

Flag­ship’s gene edit­ing start­up Tessera cuts jobs as it shifts re­sources to clin­ic

Last year
People
Cell/Gene Tx

Ex­clu­sive: Marc Tessier-Lav­i­gne on leav­ing Stan­ford and join­ing biotech’s new AI mega-start­up

Last year
People
AI

In­cyte inks $750M deal for im­mune and neu­ro biotech Escient

Last year
Deals

Why VC leg­end Bob Nelsen is mak­ing the biggest ini­tial bet of his 37-year ca­reer on Xaira

Last year
People
AI

Ex­clu­sive: In $1B+ bet on AI, bio­phar­ma heavy­weights back new start­up to up­end drug R&D

Last year
Deals
R&D

Re­gen­eron’s $500M fund spot­lights cor­po­rate ven­ture’s in­flu­en­tial role in biotech

Last year
Financing
Pharma

Ex­clu­sive: Gene edit­ing start­up Seam­less hires ex-Ho­mol­o­gy leader, dou­bles seed round

Last year
People
Cell/Gene Tx

Cor­ner Ther­a­peu­tics to hy­per­ac­ti­vate ‘the brains of the im­mune sys­tem’ with $54M launch

Last year
Financing

Obe­si­ty drug­mak­er lands first bio­phar­ma up­list­ing on­to Nas­daq since last sum­mer

Last year
Financing

Ex­clu­sive: Sidu­ma, a biotech from Arv­inas' sci­en­tif­ic founder, shut­ters due to 'fi­nanc­ing en­vi­ron­men­t'

Last year
People

An­oth­er ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M

Last year
Financing
First page Previous page 16171819202122 Next page Last page
A service from the Financial Times